Carboplatin
Drug ingredientActive ShortageCAS 41575-94-4
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 284390 · basket
These shares come from HS customs code 284390, which covers 65 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Belgium
- Australia
- Switzerland
- Turkey
- Austria
- Mexico
- Latvia
- South Korea
- Romania
- Taiwan
- Poland
17 FDA-registered drug labelers
Why It Matters
Appears in 2 drug and cosmetic product listings (FDA).
- •Carboplatin
- •Kyxata
- Current shortage
Carboplatin Injection
Shortage listed since April 28, 2023
Manufacturer reports: 1 unavailable, 1 limited, 1 available
Chemical Identity
Data Sources
- PubChem · compound 426756Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Carboplatin (CAS 41575-94-4) https://chemicalindependence.com/chemical/41575-94-4/ PubChem: 426756. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/426756 FDA National Drug Code directory: CAS 41575-94-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 41575-94-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 284390 for CAS 41575-94-4. Reporting year: 2024. https://usatrade.census.gov/